|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1399 NEW YORK AVE, NW, SUITE 725 |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Deerfield |
State | IL |
Zip Code | 60015 |
Country | USA |
|
5. Senate ID# 309071-12
|
||||||||
|
6. House ID# 384420000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Leslie Higgins, Director of Federal Government Relations |
Date | 04/21/2008 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
S. 1951/H.R. 3700 the "Fair Medicaid Drug Payment Act of 2007" - Medicaid reimbursement for generic drugs as related to average manufacturer's price (AMP) and federal upper limits (FULs); H.R. 3140 "Saving Our Community Pharmacies Act of 2007" - Medicaid reimbursement for generic drugs as related to AMP and FULs; S. 980 the "Online Pharmacy Consumer Protection Act of 2007" - regarding amendments to the control substances act relating to the delivery of control substances over the internet;
S. 2408 the "E-Meds Act of 2007" - e-prescribing in Medicare - regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 3580 the 'Food and Drug Administration Amendments Act of 2007" - Sec 505d regarding pharmaceutical safety and anti-counterfeiting; S. 1082 the "FDA Revitalization Act of 2007" -Sec. 514 regarding anti-counterfeiting technology, Sec. 807 internet pharmacy, MedGuides for prescription drugs; H.R. 2900 the "Food and Drug Amendments Act of 2007" - Sec. 910 regarding pharmaceutical safety, MedGuides for prescription drugs; H.R.5491 the "Pharmacy Technician Training and Registration Act of 2008 regarding grant programs to allow states to establish and implement technician registration programs; H.R. 5629 the "Pathway to Biosimilars Act" regarding licensure pathway for biogenerics; H.R. 1956 the "Patient Protection and Innovative Biologic Medicines Act of 2007" regarding amending the Public Health Service Act to provide for approval of biosimilar products; S. 1145 the "Patent Reform Act of 2007" Sec 12 regarding inequitable conduct and the development of a pathway for approval of biogenerics; Electronic Prescribing of Controlled Substances - regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances - no specific legislation; TRICARE pharmacy program as it relates to Federal Supply Schedule pricing for drugs dispensed in retail pharmacies and the copays at retail pharmacy - no specific legislation
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), White House Office, Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Leslie |
Higgins |
|
|
|
Susie |
Schulte |
|
|
|
Heather |
Smith |
|
|
|
Debbie |
Garza |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
S. 1276/H.R. 2747 the "Methamphetamine Production Prevention Act of 2007" - electronic logbooks, tracking systems; H.R. 3610 the "Food and Drug Import Safety Act of 2007" - Sec. 6 regarding country of origin labeling for drugs and devices;
S. 2274 the "Dextromethrophan Abuse Reduction Act of 2007" - regarding amending the Controlled Substances Act to prevent the abuse of DXM, limiting sales to those over the age of 18; S. 2045 the "Consumer Product Safety Commission Reform Act of 2007" - Sec. 23 (e) regarding the implementation of new lead standards; H.R. 1108 the "Family Smoking Prevention and Tobacco Control Act" Title I, Chapter IX Sec. 913 regarding equal treatment of retail outlets and Sec 917 regarding preservation of state and local authority.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Leslie |
Higgins |
|
|
|
Susie |
Schulte |
|
|
|
Heather |
Smith |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
Organized Retail Crime - as related to federalizing the crime - no specific legislation introduced
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Leslie |
Higgins |
|
|
|
Susie |
Schulte |
|
|
|
Heather |
Smith |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 2914 the "Medicare IVIG Access Act of 2007" regarding improved access to immune globulins. Sec 4 regarding coverage of home administration of IVIG; Pharmacy enhancements for consideration to the Medicare Modernization Act - no specific legislation this reporting period
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Leslie |
Higgins |
|
|
|
Susie |
Schulte |
|
|
|
Heather |
Smith |
|
|
|
Bryan |
Schneider |
|
|
|
Debbie |
Garza |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |